Showing results (631-640 of 844) with videos related to
Sort By:
Pageof 85
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?J T Ribeiro, L T Macedo, G Curigliano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II studyO Pagani, C Sessa, F Nolè, et al.Journal of Cancer Research and Clinical Oncology|November 19, 2015
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory studyChiara Catania, Irene Feroce, Monica Barile, et al.Clinical Breast Cancer|December 12, 2013
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expressionAlessandra Balduzzi, Vincenzo Bagnardi, Nicole Rotmensz, et al.Clinical Breast Cancer|May 3, 2015
Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast CancerGiuseppe Cancello, Vincenzo Bagnardi, Claudia Sangalli, et al.Cancers|June 2, 2021
IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck CancerMai Badarni, Manu Prasad, Artemiy Golden, et al.Plos One|September 3, 2011
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talkShirin Elhaik-Goldman, Daniel Kafka, Rami Yossef, et al.Journal of the National Cancer Institute|May 21, 2019
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-AnalysisFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.Breast Cancer Research and Treatment|September 21, 2004
Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?Marzio E E Sabbioni, Jürg Bernhard, Hans-Peter Siegrist, et al.Pageof 85